Small Company Perspective on US Early Feasibility Studies - Vicki L. Bebeau, RN

↳ This is a section part of Moment: CRT 2015 Valve & Structural - Transcatheter Mitral Therapy: Regulatory Pathways for an Emerging Technology

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Small Company Perspective on US Early Feasibility Studies presented by Vicki L. Bebeau, RN at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons

Session Name: Transcatheter Mitral Therapy: Regulatory Pathways for an Emerging Technology

Track: Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
Optimizing Clinical Trial Designs for Mitral Therapy - Gregg W. Stone, MD
Valve Replacement Devices - Stanton Rowe
US Early Feasibility Studies for Transcatheter Mitral Therapy - Changfu Wu, PhD
Small Company Perspective on US Early Feasibility Studies - Vicki L. Bebeau, RN
Loading Simple Education